scispace - formally typeset
A

Andrew D. Devereau

Researcher at Queen Mary University of London

Publications -  9
Citations -  984

Andrew D. Devereau is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 2 publications receiving 790 citations.

Papers
More filters
Journal ArticleDOI

The Human Phenotype Ontology in 2017

Sebastian Köhler, +60 more
TL;DR: The progress of the HPO project is reviewed, including specific areas of expansion such as common (complex) disease, new algorithms for phenotype driven genomic discovery and diagnostics, integration of cross-species mapping efforts with the Mammalian Phenotype Ontology, an improved quality control pipeline, and the addition of patient-friendly terminology.
Journal ArticleDOI

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

TL;DR: In this study, whole genome sequencing for the detection of repeat expansions showed high sensitivity and specificity, and it led to identification of neurological repeat expansion disorders in previously undiagnosed patients.
Journal ArticleDOI

Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome

TL;DR: In this article , the authors examined the molecular characteristics of Gly substitutions that determine the severity of clinical features, including exon location (1 to 20 or 21 to carboxyl terminus), being adjacent to a non-collagenous region, and the degree of instability caused by the replacement residue.
Journal ArticleDOI

Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy

Robert Lesurf, +115 more
- 14 Mar 2022 - 
TL;DR: In this paper , the authors analyzed whole-genome sequencing (WGS) data in a discovery cohort of 209 pediatric CMP patients and 1953 independent replication genomes and exomes and provided strong evidence for the genomic contribution of functionally active variants in new genes and in regulatory elements of known CMP genes to early onset CMP.